• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉瘤化疗。

Sarcoma chemotherapy.

机构信息

Mayo Clinic, Rochester, MN, USA.

出版信息

J Am Acad Orthop Surg. 2013 Aug;21(8):480-91. doi: 10.5435/JAAOS-21-08-480.

DOI:10.5435/JAAOS-21-08-480
PMID:23908254
Abstract

Sarcomas are a rare, heterogeneous group of malignant tumors of the bone or soft tissue. Although historically intended for the pharmaceutical treatment of microbes, today chemotherapy is used in orthopaedic oncology and is arguably the primary reason for improved survivorship. Agents such as anthracyclines (eg, doxorubicin), alkylating agents (eg, cyclophosphamide, ifosfamide), antimetabolites (eg, methotrexate), topoisomerase inhibitors (eg, etoposide [VP-16]), vinca alkaloids (eg, vincristine), and cytotoxic antibiotics (eg, actinomycin D) are used in various combinations to manage different types of tumors. Side effects are common and range from mild to severe. The effectiveness of the chemotherapy regimen correlates with the extent of tumor necrosis.

摘要

肉瘤是一种罕见的、异质性的恶性肿瘤,发生于骨或软组织。虽然历史上用于治疗微生物的药物,但今天在骨肿瘤学中使用化疗,可以说是提高生存率的主要原因。阿霉素(如多柔比星)、烷化剂(如环磷酰胺、异环磷酰胺)、抗代谢物(如甲氨蝶呤)、拓扑异构酶抑制剂(如依托泊苷[VP-16])、长春碱类(如长春新碱)和细胞毒性抗生素(如放线菌素 D)等药物以不同的组合方式用于治疗不同类型的肿瘤。副作用是常见的,从轻微到严重不等。化疗方案的有效性与肿瘤坏死的程度相关。

相似文献

1
Sarcoma chemotherapy.肉瘤化疗。
J Am Acad Orthop Surg. 2013 Aug;21(8):480-91. doi: 10.5435/JAAOS-21-08-480.
2
[Soft tissue sarcoma: postoperative chemotherapy].[软组织肉瘤:术后化疗]
Gan To Kagaku Ryoho. 2004 Sep;31(9):1324-30.
3
[Preoperative adjuvant therapy for primary malignant bone tumors].[原发性恶性骨肿瘤的术前辅助治疗]
Gan To Kagaku Ryoho. 2007 Nov;34(11):1750-4.
4
[Chemotherapy of advanced bone and soft tissue sarcoma].[晚期骨肉瘤和软组织肉瘤的化疗]
Gan To Kagaku Ryoho. 1984 Sep;11(9):1757-63.
5
Current perspectives in the management of soft-tissue sarcoma. The role of chemotherapy in multimodality therapy.软组织肉瘤管理的当前观点。化疗在多模式治疗中的作用。
Can J Surg. 1988 Nov;31(6):390-6.
6
Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.晚期软组织肉瘤单药及联合化疗的结果。对临床决策的启示。
Hematol Oncol Clin North Am. 1995 Aug;9(4):765-85.
7
Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.长春新碱、多柔比星、环磷酰胺、异环磷酰胺和依托泊苷联合用于高危肉瘤的治疗:圣裘德儿童研究医院的经验
Cancer. 2006 Apr 15;106(8):1846-56. doi: 10.1002/cncr.21810.
8
[Medical treatment of soft-tissue sarcomas in adults].[成人软组织肉瘤的医学治疗]
Bull Cancer. 1985;72(3):183-201.
9
High-dose ifosfamide in the treatment of sarcomas of soft tissues and bone.大剂量异环磷酰胺治疗软组织和骨肉瘤
Semin Oncol. 1996 Jun;23(3 Suppl 6):22-6.
10
Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.新辅助长春新碱、异环磷酰胺和阿霉素联合粒细胞集落刺激因子支持治疗晚期非横纹肌肉瘤软组织肉瘤儿童和青少年的II期试验:一项儿科肿瘤学组研究
J Clin Oncol. 2005 Jun 20;23(18):4031-8. doi: 10.1200/JCO.2005.03.209. Epub 2005 Mar 14.

引用本文的文献

1
A Phase I Study of Carfilzomib with Cyclophosphamide and Etoposide in Relapsed and Refractory Leukemia and Solid Tumors.卡非佐米联合环磷酰胺和依托泊苷治疗复发难治性白血病和实体瘤的I期研究
Cancers (Basel). 2025 Sep 6;17(17):2924. doi: 10.3390/cancers17172924.
2
Recent advances in hydrogel-assisted treatment of malignant bone tumors.水凝胶辅助治疗恶性骨肿瘤的最新进展
Mater Today Bio. 2025 Jul 14;33:102088. doi: 10.1016/j.mtbio.2025.102088. eCollection 2025 Aug.
3
Assessment of medical students' knowledge of primary limb sarcomas.
评估医学生对原发性肢体肉瘤的知识掌握情况。
BMC Med Educ. 2024 Feb 13;24(1):138. doi: 10.1186/s12909-024-05111-z.
4
Comparison of bolus administration and short-term infusion versus long-term infusion of doxorubicin in terms of cardiotoxicity and efficacy.在心脏毒性和疗效方面比较阿霉素推注给药及短期输注与长期输注的差异。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):3771-3780. doi: 10.1007/s00210-023-02886-8. Epub 2023 Dec 14.
5
The Survival Outcomes, Prognostic Factors and Adverse Events following Systemic Chemotherapy Treatment in Bone Sarcomas: A Retrospective Observational Study from the Experience of the Cancer Referral Center in Northern Thailand.骨肉瘤全身化疗后的生存结果、预后因素及不良事件:一项基于泰国北部癌症转诊中心经验的回顾性观察研究。
Cancers (Basel). 2023 Mar 26;15(7):1979. doi: 10.3390/cancers15071979.
6
Selective Effects of Cold Atmospheric Plasma on Bone Sarcoma Cells and Human Osteoblasts.冷大气等离子体对骨肉瘤细胞和人成骨细胞的选择性作用
Biomedicines. 2023 Feb 17;11(2):601. doi: 10.3390/biomedicines11020601.
7
Anticancer effects of licochalcones: A review of the mechanisms.甘草查耳酮类化合物的抗癌作用:作用机制综述
Front Pharmacol. 2023 Jan 23;14:1074506. doi: 10.3389/fphar.2023.1074506. eCollection 2023.
8
A 20.5 cm Malignant Peripheral Nerve Sheath Tumor of the Anterior Mediastinum Showing Response to Neoadjuvant Therapy.一例位于前纵隔的20.5厘米恶性周围神经鞘膜瘤对新辅助治疗有反应
Cureus. 2022 Nov 9;14(11):e31299. doi: 10.7759/cureus.31299. eCollection 2022 Nov.
9
The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade.KrasG12D;Trp53fl/fl 小鼠未分化多形性肉瘤模型中巨噬细胞丰富,淋巴细胞稀少,并对免疫检查点阻断具有抗性。
PLoS One. 2021 Jul 9;16(7):e0253864. doi: 10.1371/journal.pone.0253864. eCollection 2021.
10
The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study.β-肾上腺素能受体拮抗剂普萘洛尔抵消了不同肉瘤亚型对化疗药物的耐药机制:一项初步研究。
Sci Rep. 2020 Jun 26;10(1):10465. doi: 10.1038/s41598-020-67342-6.